IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 1 filers reported holding IVERIC BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3,890,568 | +91.1% | 98,896 | +18.2% | 0.00% | 0.0% |
Q1 2023 | $2,036,276 | +1354.3% | 83,694 | +1179.7% | 0.00% | – |
Q4 2022 | $140,022 | -42.8% | 6,540 | -52.1% | 0.00% | – |
Q3 2022 | $245,000 | +57.1% | 13,658 | -16.3% | 0.00% | – |
Q2 2022 | $156,000 | -86.4% | 16,320 | -76.0% | 0.00% | – |
Q1 2022 | $1,145,000 | -35.9% | 67,930 | -36.4% | 0.00% | – |
Q4 2021 | $1,785,000 | +257.0% | 106,767 | +247.4% | 0.00% | – |
Q3 2021 | $500,000 | +306.5% | 30,737 | +57.2% | 0.00% | – |
Q2 2021 | $123,000 | -52.5% | 19,547 | -53.3% | 0.00% | – |
Q1 2021 | $259,000 | -78.5% | 41,892 | -76.0% | 0.00% | – |
Q4 2020 | $1,204,000 | +81.9% | 174,215 | +48.8% | 0.00% | – |
Q3 2020 | $662,000 | +438.2% | 117,115 | +390.2% | 0.00% | – |
Q2 2020 | $123,000 | +6050.0% | 23,892 | +3639.0% | 0.00% | – |
Q1 2020 | $2,000 | -71.4% | 639 | -13.5% | 0.00% | – |
Q4 2019 | $7,000 | – | 739 | 0.0% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 739 | -97.4% | 0.00% | – |
Q2 2019 | $36,000 | – | 27,929 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |